Phase III
Russian coronavirus vaccine trials begin in UAE as cases rise
Abu Dhabi has started Phase III clinical trials of Russia’s experimental COVID-19 vaccine, known as Sputnik V, amid a surge in infections in the United Arab Emirates, Abu Dhabi’s media office said on Thursday. The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 volunteers to be vaccinated at a hospital in the emirate of Abu Dhabi. Two doses of the vaccine will be given, 20 days apart, to volunteers, the statement said. Participants will have to be 18 years or older, have not previously been infected with COVID-19 or participated in other COVID-19 vaccine trials, it said. The UAE is also conducting Phase III trials of a COVID-19 vaccine developed by China National Pharmaceutical Group (Sinopharm). The UAE has approved the vaccine and it is a...
India’s Serum Institute seeks approval for COVID-19 vaccine
The Serum Institute of India, the world’s largest vaccine producer by volume, has sought government approval for emergency-use authorisation of the coronavirus vaccine that it has developed in partnership with the University of Oxford and British drugmaker AstraZeneca. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD,” the company CEO Adar Poonawalla tweeted on Monday. The experimental vaccine can be stored at two to eight degrees Celsius and can be distributed more easily in India, which has the world’s second-highest number of infections at 9.6 million. The company has applied to the Drugs Controller General of India (DCGI), with Poonawalla saying the vaccine will “save countless lives” witho...
